Cosmetic Ingredient Maker JAKA Biotech Reaches $390 Million Valuation in IPO
Shanghai-based active ingredient supplier JAKA Biotech went public on the Beijing Stock Exchange, raising $19.3 million to expand plant extract capacity.
Archive
Shanghai-based active ingredient supplier JAKA Biotech went public on the Beijing Stock Exchange, raising $19.3 million to expand plant extract capacity.